Will Serena Williams's weight-loss admission help shed the stigma of anti-obesity drugs?
Serena Williams has revealed that she used an anti-obesity drug to help with her weight loss
The tennis great revealed this week that she had used the prescription medication Saxenda, sparking conversations online about the stigma around obesity and weight-loss treatments.
What impact will this disclosure have on the perception of anti-obesity drugs?
Many people living with obesity have faced discriminatory attitudes and barriers to healthcare due to the widespread belief that obesity is a matter of self-control.
Recognizing that obesity is a complex, chronic condition that requires clinical management, including the use of anti-obesity medications, is crucial.
Being overweight carries a number of health risks, including hypertension, diabetes, and high cholesterol. These conditions can be alleviated through weight loss, providing a clear incentive for many individuals.
The Science Behind Saxenda
Saxenda, the drug Williams used, is a glucagon-like peptide (GLP-1) agonist, stimulating the release of insulin and reducing blood sugar levels. It is injected once daily and works by mimicking the action of a naturally occurring hormone that regulates blood sugar levels.
A treatment plan involving Saxenda typically includes lifestyle changes like healthier eating and regular physical activity. It is important to note that Saxenda is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).
The Future of Obesity Treatments
It is important to recognize that many people live with obesity, and effective, accessible treatments are needed. Studies show that anti-obesity drugs are safe and effective, yet they are vastly underused due to outdated perceptions and societal biases.
Williams' disclosure is timely as it encourages a more supportive approach to obesity treatment, where individuals can seek care without fear of judgment or stigma. It is hoped this will pave the way for more open discussions and education about obesity as a health condition.
